Treatments & Interventions
Naltrexone hydrochloride
substance
Mesoridazine besylate
substance
Ondansetron hydrochloride
substance
Citalopram hydrobromide
substance
Ondansetron
substance
Citalopram
substance
Mesoridazine
substance
Naltrexone
substance
Disulfiram
substance
Acamprosate
substance
Acamprosate calcium
substance
Ondansetron hydrochloride anhydrous
substance
Clinical Trials
Recent Trials
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
NIAAA Natural History Protocol
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 66590003
- UMLS CUI
- C0001973
- Fully Specified Name
- Alcohol dependence (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 1
- Known Treatments
- 12
- Clinical Trials
- 116
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.